Ltd Otsuka News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPeter greenleafRobert fosterKaren smithJeffrey baileyAmerican college of rheumatologyAmerican society of nephrologyExchange commission electronic document gatheringAurinia pharmaceuticalsAurinia pharmaceuticals incCompany annual report on formLtd otsukaCompany quarterly report on formOtsuka pharmaceutical coScottish medicines consortium

Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update

/PRNewswire/ Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United kingdomUnited statesDavida spellmanMercedes carrascoJohn butlerLtd otsukaDrug administrationAkebia therapeutics incExchange commissionUs food drug administrationOtsuka pharmaceuticals coEuropean medicines agencyComplete response letterChief executive officerNew drug applicationOtsuka pharmaceuticals

Akebia Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights

/PRNewswire/ Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United kingdomUnited statesVifor pharmaDell faulkinghamMercedes carrascoJohnp butlerVifor pharma groupLtd otsukaDrug administrationAkebia therapeutics incExchange commissionJapan ministry of healthEuropean medicines agencyOtsuka pharmaceuticals coPrescription drug user fee actChief executive officer